{"name":"Li Huiping","slug":"li-huiping","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HdGtzRGJ6clRsZWc3b1RNRnNrdXZxRlpjUHF6OEdRanhiUXNkSjg3aWpsRFplOGdkRFZDNk1JMFk5RTd3UU5ONzd0Yi03ZjhWUWVTeXhnVHk1eWpHMnBJ?oc=5","date":"2025-06-03","type":"trial","source":"Nature","summary":"A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial - Nature","headline":"A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE03b2R3MExmRDVDRkJHdE54aEx3M2ZzcG9ub0IyZGViRXJsdWYxd05EUnVISUV3WEE2d1NBcjV5dmxXSVNtRTZsRWVGbzlBMkxCa3JMcURuV3JHU2dxdERsZ05wT2xfUndI?oc=5","date":"2023-08-17","type":"pipeline","source":"Wiley Online Library","summary":"Epinodosin suppresses the proliferation, invasion, and migration of esophageal squamous cell carcinoma by mediating miRNA-143-3p/Bcl-2 axis - Wiley Online Library","headline":"Epinodosin suppresses the proliferation, invasion, and migration of esophageal squamous cell carcinoma by mediating miRN","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}